| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |